Get started
Author

Amel Ladjeroud

Observed names: A Ladjeroud, A. Ladjeroud
Observed institution: Institut Jules Bordet
ORCID: 0009-0002-8590-0974
Observed ORCID: 0009-0002-8590-0974
OpenAlex ID: A5080653207
Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria
2020 · F Smaili, A Boudjella, et al. · Cancer Treatment and Research Communications · 11
PDF
Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]
2022 · Mudieddine Seoud, Amel Ladjeroud, et al. · Current Women s Health Reviews · 2
Impact of Carboplatin on Long-Term Survival after Neoadjuvant Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: An Algerian Cohort Study
2026 · Samira Merah, Amal Kouchkar, et al. · Archives of Breast Cancer
PDF
Androgen receptor expression in triple negative breast cancer: an Algerian population study
2025 · Amel Hedjem, Amal Kouchkar, et al. · Libyan Journal of Medicine
PDF
Abstract P6-05-48: Perceptions About Breast Cancer in North Africa: A Social Listening Project
2023 · Amel Ladjeroud, Ahlem El Ghoul, et al. · Cancer Research
Amélioration de la réponse histologique complète (pCR) par chimiothérapie néoadjuvante à base de sel de platine dans les cancers du sein triple négatif
2019 · Amel Ladjeroud, Kamel Bouzid
L’association hormonothérapie-thérapie ciblée dans le cancer du sein
2010 · A. Ladjeroud, A. Awada, et al. · ONCOLOGIE
Works count: 7
Citation count: 13
H-index: 2
I10-index: 1
Year
Topic
Type